These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10577981)

  • 1. FDA perspective on anti-TNF treatments.
    Schwieterman WD
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I90-1. PubMed ID: 10577981
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Okada SK; Siegel JN
    JAMA; 2006 Nov; 296(18):2201-2; author reply 2203-4. PubMed ID: 17090760
    [No Abstract]   [Full Text] [Related]  

  • 3. Once-a-month injection approved to treat three types of arthritis.
    Thompson CA
    Am J Health Syst Pharm; 2009 Jun; 66(11):968. PubMed ID: 19451600
    [No Abstract]   [Full Text] [Related]  

  • 4. Rheumatoid Arthritis - Anti-TNF.
    Chaabo K; Kirkham B
    Int Immunopharmacol; 2015 Aug; 27(2):180-4. PubMed ID: 25962818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comment of the Society of Pediatric and Adolescent Rheumatology on the US Food and Drug Administration (FDA) announcement regarding cases of malignancy in anti-TNF-treated patients].
    Hospach T; Haas JP; Huppertz HI; Keitzer R; Michels H; Trauzeddl R; Föll D; Dannecker G; Horneff G
    Z Rheumatol; 2009 Mar; 68(2):162-4. PubMed ID: 19214541
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis: Anti-TNF and anti-IL-17 antibodies--better together!
    Buckland J
    Nat Rev Rheumatol; 2014 Dec; 10(12):699. PubMed ID: 25348041
    [No Abstract]   [Full Text] [Related]  

  • 7. [TNF-alpha blocker in rheumatoid arthritis. Who should be treated with the new substances?].
    MMW Fortschr Med; 2000 Nov; 142(44):6. PubMed ID: 11107796
    [No Abstract]   [Full Text] [Related]  

  • 8. TNF alpha blockade in rheumatoid arthritis--time for caution or enthusiasm?
    Hamilton JD; Wilson HE; Madhok R; McInnes IB; Capell HA
    Scott Med J; 2001 Jun; 46(3):67-70. PubMed ID: 11501322
    [No Abstract]   [Full Text] [Related]  

  • 9. [TNF-alpha antagonists in therapy of rheumatoid arthritis].
    Gross WL; Gause A
    Z Rheumatol; 2003 Jun; 62(3):217. PubMed ID: 12931691
    [No Abstract]   [Full Text] [Related]  

  • 10. Tailored approach to rheumatoid arthritis treatment with TNF inhibitors: where do we stand?
    Caporali R; Codullo V; Cipriani P; Giacomelli R
    Rheumatology (Oxford); 2018 Oct; 57(57 Suppl 7):vii1-vii4. PubMed ID: 30289536
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug treatments for rheumatoid arthritis: looking backwards to move forwards.
    Miossec P
    BMJ; 2015 Mar; 350():h1192. PubMed ID: 25769296
    [No Abstract]   [Full Text] [Related]  

  • 12. Promoting science over serendipity in prescribing anti-TNF therapy.
    Chee MM; Alcorn N; Paterson K; Madhok R
    Rheumatology (Oxford); 2009 Aug; 48(8):865-6. PubMed ID: 19403738
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination DMARD therapy for rheumatoid arthritis.
    Kremer JM
    Manag Care; 2001 Jul; 10(7 Suppl):10-4. PubMed ID: 11729428
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
    González-Gay MA; Agudo M
    Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
    [No Abstract]   [Full Text] [Related]  

  • 15. If it works why can't we have it? Sequential anti-TNF therapy in the UK.
    Deighton C
    Rheumatology (Oxford); 2010 Dec; 49(12):2235-6. PubMed ID: 20685801
    [No Abstract]   [Full Text] [Related]  

  • 16. Access to disease modifying treatments for rheumatoid arthritis patients.
    Furst DE; Breedveld FC; Burmester GR; Crofford L; Emery P; Feldman M; Kalden JR; Kavanaugh A; Keystone E; Lipsky PE; Maini RN; Moreland L; Smolen JS; Van De Putte L; Vischer T; Weinblatt M; Weissman M
    Ann Rheum Dis; 1999 Nov; 58 Suppl 1(Suppl 1):I129-30. PubMed ID: 10577989
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug: comments on the article by Söderlin et al.
    Park SJ; Shin JI
    Scand J Rheumatol; 2012 Oct; 41(5):411-2. PubMed ID: 23043533
    [No Abstract]   [Full Text] [Related]  

  • 18. Do we really need five TNF antagonists?
    Ruderman EM
    Rheumatology (Oxford); 2010 Jun; 49(6):1028-9. PubMed ID: 20172993
    [No Abstract]   [Full Text] [Related]  

  • 19. An error in the revised anti-TNF therapy guidelines for adult RA.
    Deighton C; Ledingham J
    Rheumatology (Oxford); 2006 Sep; 45(9):1170. PubMed ID: 16769774
    [No Abstract]   [Full Text] [Related]  

  • 20. [TNF antagonists in therapy of rheumatoid arthritis].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.